Prosecution Insights
Last updated: August 06, 2026
Application No. 19/100,465

FULLY CANULATED SOFT TISSUE TO BONE ANCHOR AND METHOD

Non-Final OA §102§103
Filed
Jan 31, 2025
Priority
Jul 31, 2022 — provisional 63/393,962 +1 more
Examiner
BACHMAN, LINDSEY MICHELE
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Shoulder Solutions Corporation
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
3y 1m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
294 granted / 608 resolved
-21.6% vs TC avg
Strong +42% interview lift
Without
With
+42.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 8m
Avg Prosecution
24 currently pending
Career history
640
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
52.2%
+12.2% vs TC avg
§102
19.1%
-20.9% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 608 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 13-15 and 18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Nadim et al. (US Patent Publication 2019/0216455). Claim 13: Nadim’465 discloses an implant (10) that is cannulated for anchoring a suture and used with a k-wire comprising: a tip (20) having a tip front (left side of the tip 20, with respect to the page in Figures 2, 3), a tip central axis (central axis is co-linear with element 72 in Figure 1) and a tip k-wire passage (90) wherein the tip k-wire passage surrounds the tip central axis (Figure 3), and an least one disc (30): each at least one disc having a disc front (left side of the disc 30, with respect to the page, in Figures 2, 3), a disc back (right side of the disc 30, with respect to the page in Figures 2, 3), a disc side (outer circumferential surface of 30), a disc central axis (same as tip central axis of the tip; it is co-linear with element 72 in Figure 1) and a disc k-wire passage (90; Figure 3) surrounding the disc central axis and at least one disc suture passage (32a) separated from the disc k-wire passage, and a screw (40) having a screw back (right side of the screw, with respect to the page, in Figures 2, 3, a screw central axis (central axis is co-linear with element 72 in Figure 1) and a screw k-wire passage (90) wherein the screw k-wire passage surrounds the screw central axis, and wherein the tip k-wire passage, the disc k-wire passage for each at least one disc, and the screw passage are aligned (Figures 1, 3), and wherein the tip front is an implant front and the screw back is an implant back (Figures 1-3),and wherein the implant from the implant front to the implant back includes, in order, the tip from the tip front to the tip back, each at least one disc each disc from the at least one disc front to the at least one disc back, and the screw from the screw front to the screw back (Figures 2, 3). Claim 14: Nadim’465 discloses each at least one disc suture passage (32a, 32b) includes: a disc suture passage entrance (32a) selected from the group consisting of: the disc suture passage entrance extending to the disc front, and the disc suture passage entrance extending to the disc side, and the disc suture passage entrance extending to the disc back (the disc suture entrance passage extends to the side; Figure 4 shows suture 50 passing through disc suture passage 32a, 32b), and a disc suture passage exit (32b) selected from the group consisting of: the disc suture passage exit extending to the disc front, the disc suture passage exit extending to the disc side, and the disc suture passage entrance extending to the disc back (the disc suture passage extends to the side; Figure 4 shows suture 50 passing through disc suture passage 32a). Claim 15: Nadim’465 discloses two disc suture passages (32a, 32b, 34a, 34b; Figure 9). Claim 18: Nadim’465 discloses the disc suture passage (32a, 32b) does not include corners (Figure 9). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 16-17 are rejected under 35 U.S.C. 103 as being unpatentable over Nadim’465, as applied to claim 14, further in view of DiMatteo et al. (US Patent Publication 2012/0083840). Claims 16, 17: Nadim’465 teaches two suture passages (32a, 32b and 34a, 34b). Therefore, Nadim’465 does not teach 3 or 4 suture passages, as required by claims 16 and 17, respectively. Like Nadim’465, DiMatteo’840 teaches a suture anchor with a disc (38) between a screw (14) and a tip (12). The disc (38) disc has suture passages (42a-42f) passing through it in order to accommodate additional sutures. It would have been obvious to one of ordinary skill in the art as of the effective filing date of the invention to modify the device taught by Nadim’465, with three or four suture passages, as taught by DiMatteo’840, in order to accommodate additional sutures, as needed, to perform a procedure for attaching soft tissue to bone. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LINDSEY BACHMAN whose telephone number is (571)272-6208. The examiner can normally be reached Monday-Wednesday 9:30 am-5 pm and alternating Thursdays. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Lindsey Bachman /L.B./Examiner, Art Unit 3771 27 July 2026 /ELIZABETH HOUSTON/Supervisory Patent Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jan 31, 2025
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12690870
THERAPEUTIC TREATMENT DEVICE WITH INVERTED BRAIDED VESSEL OCCLUDER
5y 7m to grant Granted Jul 28, 2026
Patent 12685555
SYSTEM AND METHOD FOR HARVESTING A TENDON
2y 1m to grant Granted Jul 21, 2026
Patent 12661117
LYMPHATIC ANASTOMOSIS DEVICES AND METHODS
4y 6m to grant Granted Jun 23, 2026
Patent 12661126
HEMOSTATIC DEVICE
2y 7m to grant Granted Jun 23, 2026
Patent 12653534
LYMPHATIC ANASTOMOSIS DEVICES AND METHODS
5y 5m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
90%
With Interview (+42.0%)
4y 8m (~3y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 608 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month